Глобальная стратегия лечения бронхиальной астмы - часть 23

133. Ostergaard P, Pedersen S. The effect of inhaled disodium cro

moglycate and budesonide on bronchial responsiveness to hist
amine and exercise in asthmatic children: a clinical comparison.
In: Godfrey S, ed. Glucocortiocosteroids in childhood asthma.
1987:5565.

134. Francis RS, McEnery G. Disodium cromoglycate compared with

beclomethasone dipropionate in juvenile asthma. Clin Allergy
1984;14(6):53740.

135. Tasche MJ, Uijen JH, Bernsen RM, de Jongste JC, van der

Wouden JC. Inhaled disodium cromoglycate (DSCG) as mainte
nance therapy in children with asthma: a systematic review.
Thorax 2000;55(11):91320.

136. Tasche MJ, van der Wouden JC, Uijen JH, Ponsioen BP, 

Bernsen RM, van SuijlekomSmit LW, et al. Randomised place
bocontrolled trial of inhaled sodium cromoglycate in 14year
old children with moderate asthma. Lancet
1997;350(9084):10604.

137. Lemanske RF, Jr., Sorkness CA, Mauger EA, Lazarus SC,

Boushey HA, Fahy JV, et al. Inhaled corticosteroid reduction and
elimination in patients with persistent asthma receiving salme
terol: a randomized controlled trial. JAMA 
2001;285(20):2594603.

138. Lazarus SC, Boushey HA, Fahy JV, Chinchilli VM, Lemanske RF, Jr.,

Sorkness CA, et al. Longacting beta2agonist monotherapy vs
continued therapy with inhaled corticosteroids in patients with
persistent asthma: a randomized controlled trial. JAMA
2001;285(20):258393.

139. Pearlman DS, Chervinsky P, LaForce C, Seltzer JM, Southern DL,

Kemp JP, et al. A comparison of salmeterol with albuterol in the
treatment of mildtomoderate asthma. N Engl J Med
1992;327(20):14205.

140. Kesten S, Chapman KR, Broder I, Cartier A, Hyland RH,

Knight A, et al. A threemonth comparison of twice daily inhaled
formoterol versus four times daily inhaled albuterol in the man
agement of stable asthma. Am Rev Respir Dis 
1991;144(3 Pt 1):6225.

141. Wenzel SE, Lumry W, Manning M, Kalberg C, Cox F, Emmett A,

et al. Efficacy, safety, and effects on quality of life of salmeterol
versus albuterol in patients with mild to moderate persistent
asthma. Ann Allergy Asthma Immunol 1998;80(6):46370.

142. Shrewsbury S, Pyke S, Britton M. Metaanalysis of increased

dose of inhaled steroid or addition of salmeterol in symptomatic
asthma (MIASMA). BMJ 2000;320(7246):136873.

143. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol

versus higherdose corticosteroid in asthma patients with symp
toms on existing inhaled corticosteroid. Allen & Hanburys
Limited UK Study Group. Lancet 1994;344(8917):21924.

144. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison

of addition of salmeterol to inhaled steroids with doubling of the
dose of inhaled steroids. Am J Respir Crit Care Med
1996;153(5):14818.

145. Pauwels RA, Sears MR, Campbell M, Villasante C, Huang S,

Lindh A, et al. Formoterol as relief medication in asthma: a
worldwide safety and effectiveness trial. Eur Respir J
2003;22(5):78794.

146. Ind PW, Villasante C, Shiner RJ, Pietinalho A, Boszormenyi NG,

Soliman S, et al. Safety of formoterol by Turbuhaler as reliever
medication compared with terbutaline in moderate asthma. 
Eur Respir J 2002;20(4):85966.

147. Tattersfield AE, Town GI, Johnell O, Picado C, Aubier M,

Braillon P, et al. Bone mineral density in subjects with mild asth
ma randomised to treatment with inhaled corticosteroids or non
corticosteroid treatment for two years. Thorax 2001;56(4):2728.

148. Boonsawat W, Charoenratanakul S, Pothirat C, Sawanyawisuth K,

Seearamroongruang T, Bengtsson T, et al. Formoterol (OXIS)
Turbuhaler as a rescue therapy compared with salbutamol pMDI

plus spacer in patients with acute severe asthma. Respir Med
2003;97(9):106774.

149. Balanag VM, Yunus F, Yang PC, Jorup C. Efficacy and safety of

budesonide/formoterol compared with salbutamol in the treat
ment of acute asthma. Pulm Pharmacol Ther 
2006;19(2):13947.

150. Bateman ED, Fairall L, Lombardi DM, English R.

Budesonide/formoterol and formoterol provide similar rapid
relief in patients with acute asthma showing refractoriness to
salbutamol. Respir Res 2006;7:13.

151. Verberne AA, Frost C, Duiverman EJ, Grol MH, Kerrebijn KF.

Addition of salmeterol versus doubling the dose of beclometha
sone in children with asthma. The Dutch Asthma Study Group.
Am J Respir Crit Care Med 1998;158(1):2139.

152. Bisgaard H. Longacting beta(2)agonists in management of

childhood asthma: A critical review of the literature. Pediatr
Pulmonol 2000;29(3):22134.

153. Bisgaard H. Effect of longacting beta2 agonists on exacerba

tion rates of asthma in children. Pediatr Pulmonol
2003;36(5):3918.

154. O’Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M,

Zhu Y, et al. Budesonide/formoterol combination therapy as both
maintenance and reliever medication in asthma. Am J Respir Crit
Care Med 2005;171(2):12936.

155. Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L,

Centanni S, et al. Efficacy and safety of budesonide/formoterol
single inhaler therapy versus a higher dose of budesonide in
moderate to severe asthma. Curr Med Res Opin
2004;20(9):140318.

156. Rabe KF, Pizzichini E, Stallberg B, Romero S, Balanzat AM,

Atienza T, et al. Budesonide/formoterol in a single inhaler for
maintenance and relief in mildtomoderate asthma: a random
ized, doubleblind trial. Chest 2006;129(2):24656.

157. Vogelmeier C, D’Urzo A, Pauwels R, Merino JM, Jaspal M,

Boutet S, et al. Budesonide/formoterol maintenance and reliever
therapy: an effective asthma treatment option? Eur Respir J
2005;26(5):81928.

158. Ng D, Salvio F, Hicks G. Antileukotriene agents compared to

inhaled corticosteroids in the management of recurrent and/or
chronic asthma in adults and children. Cochrane Database Syst
Rev 2004(2):CD002314.

159. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O’Byrne P,

Barnes PJ, et al. Effect of inhaled formoterol and budesonide on
exacerbations of asthma. Formoterol and Corticosteroids
Establishing Therapy (FACET) International Study Group. N Engl
J Med 1997;337(20):140511.

160. Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM,

Chinchilli VM, et al. Significant variability in response to inhaled
corticosteroids for persistent asthma. J Allergy Clin Immunol
2002;109(3):4108.

161. Powell H, Gibson PG. Inhaled corticosteroid doses in asthma: an

evidencebased approach. Med J Aust 2003;178(5):2235.

162. Brown PH, Greening AP, Crompton GK. Large volume spacer

devices and the influence of high dose beclomethasone dipropi
onate on hypothalamopituitaryadrenal axis function. Thorax
1993;48(3):2338.

163. Cates CC, Bara A, Crilly JA, Rowe BH. Holding chambers versus

nebulisers for betaagonist treatment of acute asthma.
Cochrane Database Syst Rev 2003(3):CD000052.

164. Turner MO, Patel A, Ginsburg S, FitzGerald JM. Bronchodilator

delivery in acute airflow obstruction. A metaanalysis. Arch
Intern Med 1997;157(15):173644.

165. Laviolette M, Malmstrom K, Lu S, Chervinsky P, Pujet JC,

Peszek I, et al. Montelukast added to inhaled beclomethasone in
treatment of asthma. Montelukast/Beclomethasone Additivity
Group. Am J Respir Crit Care Med 1999;160(6):18628.

96 ПРОГРАММА ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ БРОНХИАЛЬНОЙ АСТМЫ

166. Lofdahl CG, Reiss TF, Leff JA, Israel E, Noonan MJ, Finn AF,

et al. Randomised, placebo controlled trial of effect of a
leukotriene receptor antagonist, montelukast, on tapering
inhaled corticosteroids in asthmatic patients. BMJ
1999;319(7202):8790.

167. Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM,

James IG, et al. Randomised controlled trial of montelukast plus
inhaled budesonide versus double dose inhaled budesonide in
adult patients with asthma. Thorax 2003;58(3):2116.

168. Vaquerizo MJ, Casan P, Castillo J, Perpina M, Sanchis J,

Sobradillo V, et al. Effect of montelukast added to inhaled
budesonide on control of mild to moderate asthma. Thorax
2003;58(3):20410.

169. Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K,

et al. Fluticasone propionate/salmeterol combination provides
more effective asthma control than lowdose inhaled corticos
teroid plus montelukast. J Allergy Clin Immunol
2000;106(6):108895.

170. Fish JE, Israel E, Murray JJ, Emmett A, Boone R, Yancey SW,

et al. Salmeterol powder provides significantly better benefit
than montelukast in asthmatic patients receiving concomitant
inhaled corticosteroid therapy. Chest 2001;120(2):42330.

171. Ringdal N, Eliraz A, Pruzinec R, Weber HH, Mulder PG, Akveld M,

et al. The salmeterol/fluticasone combination is more effective
than fluticasone plus oral montelukast in asthma. Respir Med
2003;97(3):23441.

172. Dahlen B, Nizankowska E, Szczeklik A, Zetterstrom O,

Bochenek G, Kumlin M, et al. Benefits from adding the 5lipoxy
genase inhibitor zileuton to conventional therapy in aspirinintol
erant asthmatics. Am J Respir Crit Care Med 1998;157 
(4 Pt 1):118794.

173. Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP,

Haahtela T, et al. Montelukast and fluticasone compared with
salmeterol and fluticasone in protecting against asthma exacer
bation in adults: one year, double blind, randomised, compara
tive trial. BMJ 2003;327(7420):891.

174. Pedersen S, Hansen OR. Budesonide treatment of moderate

and severe asthma in children: a doseresponse study. J Allergy
Clin Immunol 1995;95 (1 Pt 1):2933.

175. Virchow JC, Prasse A, Naya I, Summerton L, Harris A. Zafirlukast

improves asthma control in patients receiving highdose inhaled
corticosteroids. Am J Respir Crit Care Med 2000;162(2 Pt 1):
57885.

176. Malone R, LaForce C, Nimmagadda S, Schoaf L, House K,

Ellsworth A, et al. The safety of twicedaily treatment with flutica
sone propionate and salmeterol in pediatric patients with persis
tent asthma. Ann Allergy Asthma Immunol 2005;95(1):6671.

177. Toogood JH, Baskerville JC, Jennings B, Lefcoe NM,

Johansson SA. Influence of dosing frequency and schedule on
the response of chronic asthmatics to the aerosol steroid,
budesonide. J Allergy Clin Immunol 1982;70(4):28898.

178. Tamaoki J, Kondo M, Sakai N, Nakata J, Takemura H, Nagai A,

et al. Leukotriene antagonist prevents exacerbation of asthma
during reduction of highdose inhaled corticosteroid. The Tokyo
JoshiIdai Asthma Research Group. Am J Respir Crit Care Med
1997;155(4):123540.

179. Mash B, Bheekie A, Jones PW. Inhaled vs oral steroids for adults

with chronic asthma. Cochrane Database Syst Rev 2000;2.

180. Ayres JG, Jyothish D, Ninan T. Brittle asthma. Paediatr Respir

Rev 2004;5(1):404.

181. Milgrom H, Fick RB, Jr., Su JQ, Reimann JD, Bush RK,

Watrous ML, et al. Treatment of allergic asthma with monoclonal
antiIgE antibody. rhuMAbE25 Study Group. N Engl J Med
1999;341(26):196673.

182. Busse W, Corren J, Lanier BQ, McAlary M, FowlerTaylor A,

Cioppa GD, et al. Omalizumab, antiIgE recombinant humanized

monoclonal antibody, for the treatment of severe allergic asth
ma. J Allergy Clin Immunol 2001;108(2):18490.

183. Humbert M, Beasley R, Ayres J, Slavin R, Hebert J, Bousquet J,

et al. Benefits of omalizumab as addon therapy in patients with
severe persistent asthma who are inadequately controlled
despite best available therapy (GINA 2002 step 4 treatment):
INNOVATE. Allergy 2005;60(3):30916.

184. Bousquet J, Wenzel S, Holgate S, Lumry W, Freeman P, Fox H.

Predicting response to omalizumab, an antiIgE antibody, in
patients with allergic asthma. Chest 2004;125(4):137886.

185. Holgate ST, Chuchalin AG, Hebert J, Lotvall J, Persson GB,

Chung KF, et al. Efficacy and safety of a recombinant antiim
munoglobulin E antibody (omalizumab) in severe allergic asth
ma. Clin Exp Allergy 2004;34(4):6328.

186. Djukanovic R, Wilson SJ, Kraft M, Jarjour NN, Steel M,

Chung KF, et al. Effects of treatment with antiimmunoglobulin E
antibody omalizumab on airway inflammation in allergic asthma.
Am J Respir Crit Care Med 2004;170(6):58393.

187. Reddel HK, Jenkins CR, Marks GB, et al. Optimal asthma con

trol, starting with high doses of inhaled budesonide. Eur Respir J
2000;16:22635.

188. Sont JK, Willems LN, Bel EH, van Krieken JH,

Vandenbroucke JP, Sterk PJ. Clinical control and histopathologic
outcome of asthma when using airway hyperresponsiveness as
an additional guide to longterm treatment. The AMPUL Study
Group. Am J Respir Crit Care Med 1999;159(4 Pt 1):104351.

189. Hawkins G, McMahon AD, Twaddle S, Wood SF, Ford I,

Thomson NC. Stepping down inhaled corticosteroids in asthma:
randomised controlled trial. BMJ 2003;326(7399):1115.

190. Powell H, Gibson PG. Initial starting dose of inhaled corticos

teroids in adults with asthma: a systematic review. Thorax
2004;59(12):10415.

191. Powell H, Gibson PG. High dose versus low dose inhaled corti

costeroid as initial starting dose for asthma in adults and chil
dren. Cochrane Database Syst Rev 2004(2):CD004109.

192. Boulet LP, Drollmann A, Magyar P, Timar M, Knight A,

Engelstatter R, et al. Comparative efficacy of oncedaily
ciclesonide and budesonide in the treatment of persistent asth
ma. Respir Med 2006;100(5):78594.

193. Masoli M, Weatherall M, Holt S, Beasley R. Budesonide once

versus twicedaily administration: metaanalysis. Respirology
2004;9(4):52834.

194. FitzGerald JM, Becker A, Sears MR, Mink S, Chung K, Lee J,

et al. Doubling the dose of budesonide versus maintenance
treatment in asthma exacerbations. Thorax 2004;59:55056.

195. Reddel HK, Barnes DJ. Pharmacological strategies for self

management of asthma exacerbations. Eur Respir J
2006;28(1):18299.

196. Harrison TW, Oborne J, Newton S, Tattersfield AE. Doubling the

dose of inhaled corticosteroid to prevent asthma exacerbations:
randomised controlled trial. Lancet 2004;363(9405):2715.

197. Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG.

Effect of budesonide in combination with formoterol for reliever
therapy in asthma exacerbations: a randomised controlled, dou
bleblind study. Lancet 2006;368(9537):74453.

198. Wenzel S. Severe asthma in adults. Am J Respir Crit Care Med

2005;172(2):14960.

199. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette

smoking. Eur Respir J 2004;24(5):82233.

200. Leggett JJ, Johnston BT, Mills M, Gamble J, Heaney LG.

Prevalence of gastroesophageal reflux in difficult asthma: rela
tionship to asthma outcome. Chest 2005;127(4):122731.

201. Heaney LG, Robinson DS. Severe asthma treatment: need for

characterising patients. Lancet 2005;365(9463):9746.

ПРОГРАММА ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ БРОНХИАЛЬНОЙ АСТМЫ  97

202. FitzGerald JM, Grunfeld A. Status asthmaticus. In:

Lichtenstein LM, Fauci AS, eds. Current therapy in allergy,
immunology, and rheumatology. 5th edition. St. Louis, MO:
Mosby; 1996:p. 637.

203. ChanYeung M, Chang JH, Manfreda J, Ferguson A, Becker A.

Changes in peak flow, symptom score, and the use of medica
tions during acute exacerbations of asthma. Am J Respir Crit
Care Med 1996;154(4 Pt 1):88993.

204. Beasley R, Miles J, Fishwick D, Leslie H. Management of asthma

in the hospital emergency department. Br J Hosp Med
1996;55(5):2537.

205. FitzGerald JM. Development and implementation of asthma

guidelines. Can Respir J 1998;5 Suppl A:858S.

206. Turner MO, Noertjojo K, Vedal S, Bai T, Crump S, FitzGerald JM.

Risk factors for nearfatal asthma. A casecontrol study in hospi
talized patients with asthma. Am J Respir Crit Care Med
1998;157(6 Pt 1):18049.

207. Ernst P, Spitzer WO, Suissa S, Cockcroft D, Habbick B,

Horwitz RI, et al. Risk of fatal and nearfatal asthma in relation to
inhaled corticosteroid use. JAMA 1992;268(24):34624.

208. Suissa S, Blais L, Ernst P. Patterns of increasing betaagonist

use and the risk of fatal or nearfatal asthma. Eur Respir J
1994;7(9):16029.

209. Joseph KS, Blais L, Ernst P, Suissa S. Increased morbidity and

mortality related to asthma among asthmatic patients who use
major tranquillisers. BMJ 1996;312(7023):7982.

210. Geelhoed GC, Landau LI, Le Souef PN. Evaluation of SaO

2

as a

predictor of outcome in 280 children presenting with acute asth
ma. Ann Emerg Med 1994;23(6):123641.

211. Cates CJ, Rowe BH. Holding chambers versus nebulisers for

betaagonist treatment of acute asthma. Cochrane Database
Syst Rev 2000;2.

212. Plotnick LH, Ducharme FM. Should inhaled anticholinergics be

added to beta2 agonists for treating acute childhood and adoles
cent asthma? A systematic review. BMJ 1998;317(7164):9717.

213. Shim CS, Williams MH, Jr. Evaluation of the severity of asthma:

patients versus physicians. Am J Med 1980;68(1):113.

214. Atta JA, Nunes MP, FonsecaGuedes CH, Avena LA, Borgiani MT,

Fiorenza RF, et al. Patient and physician evaluation of the severi
ty of acute asthma exacerbations. Braz J Med Biol Res
2004;37(9):132130.

215. Findley LJ, Sahn SA. The value of chest roentgenograms in

acute asthma in adults. Chest 1981;80(5):5356.

216. Nowak RM, Tomlanovich MC, Sarkar DD, Kvale PA, Anderson JA.

Arterial blood gases and pulmonary function testing in acute
bronchial asthma. Predicting patient outcomes. JAMA
1983;249(15):20436.

217. Cates C, FitzGerald JM, O’Byrne PM. Asthma. Clin Evidence

2000;3:686700.

218. Chien JW, Ciufo R, Novak R, Skowronski M, Nelson J, Coreno A,

et al. Uncontrolled oxygen administration and respiratory failure
in acute asthma. Chest 2000;117(3):72833.

219. Rodrigo GJ, Rodriquez Verde M, Peregalli V, Rodrigo C. Effects

of shortterm 28% and 100% oxygen on PaCO

2

and peak expira

tory flow rate in acute asthma: a randomized trial. Chest
2003;124(4):13127.

220. Rudnitsky GS, Eberlein RS, Schoffstall JM, Mazur JE, Spivey WH.

Comparison of intermittent and continuously nebulized albuterol
for treatment of asthma in an urban emergency department. Ann
Emerg Med 1993;22(12):18426.

221. Lin RY, Sauter D, Newman T, Sirleaf J, Walters J, Tavakol M.

Continuous versus intermittent albuterol nebulization in the
treatment of acute asthma. Ann Emerg Med 
1993;22(12):184753.

222. Reisner C, Kotch A, Dworkin G. Continuous versus frequent

intermittent nebulization of albuterol in acute asthma: a random
ized, prospective study. Ann Allergy Asthma Immunol
1995;75(1):417.

223. Gawchik SM, Saccar CL, Noonan M, Reasner DS, DeGraw SS.

The safety and efficacy of nebulized levalbuterol compared with
racemic albuterol and placebo in the treatment of asthma in
pediatric patients. J Allergy Clin Immunol 1999;103(4):61521.

224. Lotvall J, Palmqvist M, Arvidsson P, Maloney A, Ventresca GP,

Ward J. The therapeutic ratio of Ralbuterol is comparable with
that of RSalbuterol in asthmatic patients. J Allergy Clin Immunol
2001;108(5):72631.

225. Milgrom H, Skoner DP, Bensch G, Kim KT, Claus R, Baumgart

ner RA. Lowdose levalbuterol in children with asthma: safety
and efficacy in comparison with placebo and racemic albuterol.
J Allergy Clin Immunol 2001;108(6):93845.

226. Nowak R, Emerman C, Hanrahan JP, Parsey MV, Hanania NA,

Claus R, et al. A comparison of levalbuterol with racemic
albuterol in the treatment of acute severe asthma exacerbations
in adults. Am J Emerg Med 2006;24(3):25967.

227. Carl JC, Myers TR, Kirchner HL, Kercsmar CM. Comparison of

racemic albuterol and levalbuterol for treatment of acute asth
ma. J Pediatr 2003;143(6):7316.

228. Rodrigo GJ, Rodrigo C. Continuous vs intermittent betaago

nists in the treatment of acute adult asthma: a systematic review
with metaanalysis. Chest 2002;122(1):1605.

229. Bradding P, Rushby I, Scullion J, Morgan MD. Asrequired ver

sus regular nebulized salbutamol for the treatment of acute
severe asthma. Eur Respir J 1999;13(2):2904.

230. Travers A, Jones AP, Kelly K, Barker SJ, Camargo CA, Rowe BH.

Intravenous beta2agonists for acute asthma in the emergency
department. Cochrane Database Syst Rev 2001;2.

231. Rodrigo G, Rodrigo C, Burschtin O. A metaanalysis of the

effects of ipratropium bromide in adults with acute asthma. 
Am J Med 1999;107(4):36370.

232. Lanes SF, Garrett JE, Wentworth CE, 3rd, Fitzgerald JM, 

Karpel JP. The effect of adding ipratropium bromide to salbuta
mol in the treatment of acute asthma: a pooled analysis of three
trials. Chest 1998;114(2):36572.

233. Rodrigo GJ, Rodrigo C. Firstline therapy for adult patients with

acute asthma receiving a multipledose protocol of ipratropium
bromide plus albuterol in the emergency department. 
Am J Respir Crit Care Med 2000;161(6):18628.

234. Goggin N, Macarthur C, Parkin PC. Randomized trial of the

addition of ipratropium bromide to albuterol and corticosteroid
therapy in children hospitalized because of an acute asthma
exacerbation. Arch Pediatr Adolesc Med 2001;155(12):132934.

235. Parameswaran K, Belda J, Rowe BH. Addition of intravenous

aminophylline to beta2agonists in adults with acute asthma.
Cochrane Database Syst Rev 2000;4.

236. Ream RS, Loftis LL, Albers GM, Becker BA, Lynch RE, Mink RB.

Efficacy of IV theophylline in children with severe status asth
maticus. Chest 2001;119(5):14808.

237. Rowe BH, Bota GW, Fabris L, Therrien SA, Milner RA, Jacono J.

Inhaled budesonide in addition to oral corticosteroids to prevent
asthma relapse following discharge from the emergency depart
ment: a randomized controlled trial. JAMA 1999;281(22):211926.

238. Manser R, Reid D, Abramson M. Corticosteroids for acute

severe asthma in hospitalised patients. Cochrane Database Syst
Rev 2000;2.

239. Ratto D, Alfaro C, Sipsey J, Glovsky MM, Sharma OP. Are intra

venous corticosteroids required in status asthmaticus? JAMA
1988;260(4):5279.

240. Harrison BD, Stokes TC, Hart GJ, Vaughan DA, Ali NJ,

Robinson AA. Need for intravenous hydrocortisone in addition to

98 ПРОГРАММА ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ БРОНХИАЛЬНОЙ АСТМЫ

oral prednisolone in patients admitted to hospital with severe
asthma without ventilatory failure. Lancet 1986;1(8474):1814.

241. Gries DM, Moffitt DR, Pulos E, Carter ER. A single dose of intra

muscularly administered dexamethasone acetate is as effective
as oral prednisone to treat asthma exacerbations in young chil
dren. J Pediatr 2000;136(3):298303.

242. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW.

Early emergency department treatment of acute asthma with
systemic corticosteroids. Cochrane Database Syst Rev 2000;2.

243. Kayani S, Shannon DC. Adverse behavioral effects of treatment

for acute exacerbation of asthma in children: a comparison of
two doses of oral steroids. Chest 2002;122(2):6248.

244. Hasegawa T, Ishihara K, Takakura S, Fujii H, Nishimura T,

Okazaki M, et al. Duration of systemic corticosteroids in the
treatment of asthma exacerbation; a randomized study. Intern
Med 2000;39(10):7947.

245. O’Driscoll BR, Kalra S, Wilson M, Pickering CA, Carroll KB,

Woodcock AA. Doubleblind trial of steroid tapering in acute
asthma. Lancet 1993;341(8841):3247.

246. Lederle FA, Pluhar RE, Joseph AM, Niewoehner DE. Tapering of

corticosteroid therapy following exacerbation of asthma. A ran
domized, doubleblind, placebocontrolled trial. Arch Intern Med
1987;147(12):22013.

247. Rodrigo G, Rodrigo C. Inhaled flunisolide for acute severe asth

ma. Am J Respir Crit Care Med 1998;157(3 Pt 1):698703.

248. Rodrigo GJ. Comparison of inhaled fluticasone with intravenous

hydrocortisone in the treatment of adult acute asthma. 
Am J Respir Crit Care Med 2005;171(11):12316.

249. LeeWong M, Dayrit FM, Kohli AR, Acquah S, Mayo PH.

Comparison of highdose inhaled flunisolide to systemic corti
costeroids in severe adult asthma. Chest 2002;122(4):120813.

250. Nana A, Youngchaiyud P, Charoenratanakul S, Boe J, 

Lofdahl CG, Selroos O, et al. Highdose inhaled budesonide may
substitute for oral therapy after an acute asthma attack. J
Asthma 1998;35(8):64755.

251. FitzGerald JM, Shragge D, Haddon J, Jennings B, Lee J, Bai T,

et al. A randomized controlled trial of high dose, inhaled budes
onide versus oral prednisone in patients discharged from the
emergency department following an acute asthma exacerbation.
Can Respir J 2000;7(1):617.

252. Edmonds ML, Camargo CA, Saunders LD, Brenner BE, 

Rowe BH. Inhaled steroids in acute asthma following emergency
department discharge (Cochrane review). Cochrane Database
Syst Rev 2000;3.

253. Rowe BH, Bretzlaff JA, Bourdon C, Bota GW, Camargo CA, Jr.

Magnesium sulfate for treating exacerbations of acute asthma in
the emergency department. Cochrane Database Syst Rev
2000;2.

254. FitzGerald JM. Magnesium sulfate is effective for severe acute

asthma treated in the emergency department. West J Med
2000;172(2):96.

255. Blitz M, Blitz S, Beasely R, Diner B, Hughes R, Knopp J, et al.

Inhaled magnesium sulfate in the treatment of acute asthma.
Cochrane Database Syst Rev 2005(4):CD003898.

256. Blitz M, Blitz S, Hughes R, Diner B, Beasley R, Knopp J, et al.

Aerosolized magnesium sulfate for acute asthma: a systematic
review. Chest 2005;128(1):33744.

257. Colebourn CL, Barber V, Young JD. Use of heliumoxygen mix

ture in adult patients presenting with exacerbations of asthma
and chronic obstructive pulmonary disease: a systematic review.
Anaesthesia 2007 Jan;62(1):3442.

258. Silverman RA, Nowak RM, Korenblat PE, Skobeloff E, Chen Y,

Bonuccelli CM, et al. Zafirlukast treatment for acute asthma:
evaluation in a randomized, doubleblind, multicenter trial. Chest
2004;126(5):14809.

259. FitzGerald JM, Macklem P. Fatal asthma. Annu Rev Med

1996;47:1618.

260. Grunfeld A, Fitzgerald JM. Discharge considerations in acute

asthma. Can Respir J 1996;3:32224.

261. Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults: a

review. Chest 2004;125(3):1081102.

262. Zeiger RS, Heller S, Mellon MH, Wald J, Falkoff R, Schatz M.

Facilitated referral to asthma specialist reduces relapses in asth
ma emergency room visits. J Allergy Clin Immunol
1991;87(6):11608.

263. Gibson PG, Coughlan J, Wilson AJ, Abramson M, Bauman A,

Hensley MJ, et al. Selfmanagement education and regular
practitioner review for adults with asthma. Cochrane Database
Syst Rev 2000;(2):CD001117.

264. Baren JM, Boudreaux ED, Brenner BE, Cydulka RK, Rowe BH,

Clark S, et al. Randomized controlled trial of emergency depart
ment interventions to improve primary care followup for
patients with acute asthma. Chest 2006;129:25765.

265. Schatz M, Harden K, Forsythe A, Chilingar L, Hoffman C,

Sperling W, et al. The course of asthma during pregnancy, post
partum, and with successive pregnancies: a prospective analy
sis. J Allergy Clin Immunol 1988;81(3):50917.

266. Schatz M. Interrelationships between asthma and pregnancy: a

literature review. J Allergy Clin Immunol 1999;103(2 Pt 2):S3306.

267. Demissie K, Breckenridge MB, Rhoads GG. Infant and maternal

outcomes in the pregnancies of asthmatic women. Am J Respir
Crit Care Med 1998;158(4):10915.

268. Schatz M, Zeiger RS, Hoffman CP, Harden K, Forsythe A,

Chilingar L, et al. Perinatal outcomes in the pregnancies of asth
matic women: a prospective controlled analysis. Am J Respir Crit
Care Med 1995;151(4):11704.

269. National Asthma Education Program. Report of the working

group on asthma and pregnancy: management of asthma during
preganacy. Bethesda, MD: National Heart, Lung, and Blood
Institute. National Institutes of Health; 1993. Report No.: 
NIH Publication Number 933279A.

270. Wendel PJ, Ramin SM, BarnettHamm C, Rowe TF,

Cunningham FG. Asthma treatment in pregnancy: a randomized
controlled study. Am J Obstet Gynecol 1996;175(1):1504.

271. Murphy VE, Gibson PG, Smith R, Clifton VL. Asthma during preg

nancy: mechanisms and treatment implications. Eur Respir J
2005;25(4):73150.

272. NAEPP expert panel report. Managing asthma during pregnan

cy: recommendations for pharmacologic treatment2004
update. J Allergy Clin Immunol 2005;115(1):3446.

273. Schatz M, Zeiger RS, Harden KM, Hoffman CP, Forsythe AB,

Chilingar LM, et al. The safety of inhaled betaagonist bron
chodilators during pregnancy. J Allergy Clin Immunol
1988;82(4):68695.

274. Fung DL. Emergency anesthesia for asthma patients. Clin Rev

Allergy 1985;3(1):12741.

275. Kingston HG, Hirshman CA. Perioperative management of the

patient with asthma. Anesth Analg 1984;63(9):84455.

276. Oh SH, Patterson R. Surgery in corticosteroiddependent asth

matics. J Allergy Clin Immunol 1974;53(6):34551.

277. Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F.

Perennial rhinitis: an independent risk factor for asthma in
nonatopic subjects: results from the European Community
Respiratory Health Survey. J Allergy Clin Immunol 1999;104 
(2 Pt 1):3014.

278. Sibbald B, Rink E. Epidemiology of seasonal and perennial rhini

tis: clinical presentation and medical history. Thorax
1991;46(12):895901.

ПРОГРАММА ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ БРОНХИАЛЬНОЙ АСТМЫ  99